THERE ARE TWO FUNCTIONALLY and morphologically distinct types of adipose tissue in mammals, namely white adipose tissue (WAT), which is an endocrine organ and a major site of triglyceride storage, and brown adipose tissue (BAT), which is specialized for energy expenditure (13) . An increase in both the number and size of mature white adipocytes eventually results in obesity (19) , whereas activation of brown adipocytes seems to provide a new approach to combating obesity (9, 44) . Although genetic mechanisms that control the differentiation of white adipocytes have been clearly defined (23) , the events involved in the commitment of pluripotent stem cells to the brown adipocyte lineage are not so well defined.
Several developmental regulators hold crucial roles in adipocyte commitment and differentiation. Transforming growth factor-␤ (TGF␤) superfamily members, particularly bone morphogenetic proteins (BMPs), play significant roles in adipogenesis (22) . Certain BMPs, particularly BMP2 and BMP4, promote commitment of pluripotent stem cells to the adipocyte lineage (1, 38, 40) and drive preadipocytes to differentiate into mature white adipocytes (6, 48) . Little is known about the role of BMPs in BAT or in the balance between WAT and BAT, but BMP7 seems to be a selective and potent inducer of brown adipogenesis of both preadipocytes and multipotent fibroblasts (42) . BMP8B may also be a signaling molecule that regulates BAT thermogenesis and energy balance (49) .
Knowledge is limited about the effects of other BMPs in the development of brown adipocytes. BMP2 and BMP4 may be white adipogenesis inducers without effects on the expression of brown fat-defining markers, such as PRDM16 and UCP1 (42) , but the effects of BMPs are complex and tightly controlled by the dose and type of BMPs used in different cell models, as well as the presence of other extracellular and intracellular factors (10, 11, 24, 45) . In vivo, BMP2 initiates a cascade of events leading to the expansion, migration, and differentiation of progenitors from the peripheral nerve perineurium to brown adipose-like cells in the mouse (31) . Furthermore, forced expression of a BMP4 transgene in white adipocytes of mice gives rise to an increased number of fat-like cells with brown adipocyte characteristics comparable to those of beige or brite adipocytes (30) . Moreover, BMP4 promotion of adipogenesis is not based on a culture medium with normally required brown adipogenesis induction cocktail (42) , nor does it negate brown adipocyte-selective gene expression and mitochondrial function of the mature adipocytes (6, 7, 40) . Thus, we have asked whether BMP4 activates the program of brown adipogenesis in mesenchymal progenitor/stem cells or preadipocytes. We therefore pretreated C3H10T1/2 pluripotent cells with BMP4 and BMP7 before giving different adipogenic induction cocktails and compared the morphological and functional characteristic of their induced adipocytes.
MATERIALS AND METHODS

Chemicals and antibodies.
Recombinant human BMP4 (cat. no. 314-BP) and BMP7 (cat. no. 354-BP) were purchased from R&D Systems. Antibodies used for immunoblotting were purchased from Santa Cruz Biotechnology (anti-PPAR␥), Abcam (anti-UCP1, and anti-PRDM16), and Sigma-Aldrich (anti-␤-actin). 422/aP2 antibody was provided by Dr. Lane at Johns Hopkins University. Immobolin-P transfer membranes were obtained from Millipore, and electrophoresis supplies were purchased from Bio-Rad Laboratories. All other chemicals were purchased from Sigma Chemical unless otherwise specified.
Cell culture. C3H10T1/2 and 3T3-L1 cells were purchased from the American Type Culture Collection. Immortalized brown preadipocytes were provided by Dr. Yu-Hua Tseng at the Joslin Diabetes Center. All the cell lines were maintained in DMEM (GIBCO-BRL) with 450 mg/dl glucose supplemented with 10% calf serum (PAA) at 37°C in a 10% O2 environment unless otherwise specified. To induce the commitment, cells were plated at the same low density to obtain 20 -30% confluence on the following day. On the second day, the cells were treated with or without BMP4 or BMP7 for 6 days. After the cells had reached postconfluence (designated day 0), they were treated with three different adipocyte differentiation protocols, described below, for an additional 8 days. Adipocyte differentiation was performed by treating postconfluent cells for 48 h in DMEM containing 10% fetal serum (GIBCO-BRL), 1 g/ml insulin (I), 1 M dexamethasone (D), 0.5 mM 3-isobutyl-1-methylxanthine (M), and/or 0.125 mM indomethacin (Indo) and/or 1 nM triiodothyronine (T 3). After 48 h, the medium was withdrawn and replaced by medium supplemented with only insulin or both insulin and T 3 for 48 h. The cells were placed in growth medium without hormonal supplements. This growth medium was changed every second day. After 4 days of culture in this medium (designated day 8), the cells had a fully differentiated phenotype with massive lipid accumulation. 3T3-L1 preadipocytes were grown and differentiated as previously described (39) for up to 14 days. Cells were plated at a low density and cultured in DMEM containing 10% calf serum. Two-day-postconfluent (day 0) cells were induced to differentiate with DMEM containing 10% fetal serum, 1 g/ml insulin, 1 M dexamethasone, and 0.5 mM isobutyl methylxanthine for 2 days. The cells were fed with DMEM supplemented with 10% fetal serum and 1 g/ml insulin for 2 days and then with DMEM containing 10% fetal serum. To induce adipocyte differentiation by BMP4 or BMP7 in the brown preadipocytes, cells were grown in DMEM containing 10% fetal serum medium supplemented with a combination of BMPs, insulin (20 nM), and T 3 (1 nM) or vehicle for 8 days. To stimulate the thermogenic program, differentiated cells were incubated with 500 uM dibutyryl cAMP for 4 h.
Quantitative real-time PCR. Total RNA was isolated using TRIzol reagent (Invitrogen). Complementary DNA was prepared from 500 ng of RNA using the PrimeScript RT Master Mix (TaKaRa) diluted to a final volume of 40 l. Then, 1 l of diluted cDNA was used in a 20-l PCR reaction with SYBR Green Master Mix (Applied Biosystems). The PCR reactions were run in triplicate for each sample and quantified using the ABI Prism 7300 Sequence Detection System (Applied Biosystems). The relative expressions of the mRNAs were determined after each measurement had been normalized to the 18S RNA level acting as the internal control through the Ϫ⌬⌬CT method. All the primers were synthesized by Sangon Biotech (Shanghai). The list of primers and their sequences appear below: UCP1 (GenBank acc. no. NM_009463), 5=-AGGCTTCCAGTAC-CATTAGGT-3= and 5=-CTGAGTGAGGCAAAGCTGATTT-3=; PGC1a (GenBank acc. no. NM_008904), 5=-GTCAACAGCAAAAGC-CACAA-3= and 5=-TCTGGGGTCAGAGGAAGAGA-3=; Dio2 (GenBank acc. no. NM_010050), 5=-CAGTGTGGTGCACTGCTC-CAATC-3= and 5=-TGAACCAAAGTTGACCACCAG-3=; Elovl3 (GenBank acc. no. NM_007703), 5=-TCCGCGTTCTCATGTAGGTCT-3= and 5=-GGACCTGATGCAACCCTATGA3=; Cidea (GenBank acc. no. NM_007702), 5=-ATCACAACTGGCCTGGTTACG-3= and 5=-TACTACCCGGTGTCCATTTCT-3=; Cpt1b (GenBank acc. no. NM_009948), 5=-GCACACCAGGCAGTAGCTTT-3= and 5=-CAG-GAGTTGATTCCAGACAGGTA-3=; MCAD (GenBank acc. no. NM_007382), 5=-CAACACTCGAAAGCGGCTCA-3= and 5=-ACTT-GCGGGCAGTTGCTTG-3=; Nrf1 (GenBank acc. no. NM_001164226), 5=-CAACAGGGAAGAAACGGAAA-3= and 5=-GCACCACATTCTC-CAAAGGT-3=; Tfam (GenBank acc. no. NM_009360), 5=-GTC-CATAGGCACCGTATTGC-3= and 5=-CCCATGCTGGAAAAACAC TT-3=; Cox8b (GenBank acc. no. NM_007751), 5=-GAACCAT-GAAGCCAACGACT-3= and 5=-GCGAAGTTCACAGTGGTTCC-3=; Cox7a1 (GenBank acc. no. NM_009944), 5=-CAGCGTCATGGT-CAGTCTGT-3= and 5=-AGAAAACCGTGTGGCAGAGA-3=; PRDM 16 (GenBank acc. no. NM_027504), 5=-CAGCACGGTGAAGC-CATTC-3= and 5=-GCGTGCATCCGCTTGTG-3=; and 18S (GenBank acc. no. NM_003278), 5=-CGCCGCTAGAGGTGAAATTCT-3= and 5=-CATTCTTGGCAAATGCTTTCG-3=; Zic1 (GenBank acc. no. NM_009573), 5=-CTGTTGTGGGAGACACGATG-3= and 5=-CCTCTT CTCAGGGCTCACAG-3=; TMEM26 (GenBank acc. no. NM_177794), 5=-ACCCTGTCATCCCACAGAG-3=and 5=-TGTTTGGTGGAGTC-CTAAGGTC-3=.
Western blots. Cells were collected in lysis buffer (50 mM Tris·HCl, pH 6.8, 150 mM NaCl, 10 mM NaF, 2% SDS, 10% glycerol, and 100 mM Na 3VO4). The lysates were boiled for 10 min at 100°C and clarified by centrifugation at 12,000 g for 10 min. Protein content of the supernatants was determined with a Protein Quantitative Analysis Kit (ShenergyBiocolor). Equal amounts of proteins were separated by SDS-polyacrylamide gel electrophoresis and transferred to Immobilon-P membranes. The membranes were blocked for 2 h at room temperature and incubated with the appropriate antibody overnight at 4°C. Specifically bound primary antibodies were detected with a peroxidase-labeled secondary antibody and chemiluminescence (GE Healthcare), using a standard ECL kit and developed with Kodak Film ECL film.
Oil red O staining. Dishes were washed twice with phosphatebuffered saline (PBS) and fixed with 10% formalin for 20 min at room temperature. The cells were washed twice in PBS, stained for 4 h at room temperature with a filtered Oil red O (Sigma) working solution (0.5% Oil red O in isopropyl alcohol), and then washed twice with distilled water and visualized under an inverted microscope (Olympus).
Electron microscopy. C3H10T1/2 stem cells were treated with BMP4 (20 ng/ml) or BMP7 (100 ng/ml) for 6 days and then induced with adipogenic induction cocktail for 8 days. The cells were fixed in 2.5% glutaraldehyde, postfixed in 2% osmium tetroxide, dehydrated in an ascending gradations of ethanol, and embedded in fresh Araldite 502 epoxy resin using BEEM capsules. Ultrathin sections (60 -80 nm) were cut, mounted on 75 mesh copper grids, stained with uranyl acetate and lead citrate, and examined with a Phillips 301 transmission electron microscope.
Isolation of stromal-vascular fractions and in vitro differentiation. Twelve 4-wk-old C57BL/6 male mice were euthanized. The interscapular BAT and the inguinal subcutaneous WAT were removed, minced with scissors, and digested with 1.0 mg/ml collagenase type IA for 45 min at 37°C in DMEM containing 2% BSA. The digested tissues were filtered through sterile 100-m nylon mesh (BD Falcon) and centrifuged at 250 g for 10 min. The floating fractions consisting of adipocytes were discarded, and the pellets representing the stromalvascular fractions were plated. The cells were treated with BMP4 (20 ng/ml) or vehicle (control) for 6 days and treated with a brown adipogenic induction cocktails for 48 h in DMEM containing 10% fetal serum, 1 g/ml insulin, 1 M dexamethasone, 0.5 mM isobutylmethylxanthine, 0.125 mM indomethacin, and 1 nM T 3. The medium was then withdrawn and replaced by medium supplemented with only insulin and T3, which was changed every second day. After 6 days, the cells had a fully differentiated phenotype with massive lipid accumulation.
In vitro O2 consumption assays. The O2 consumption rates were measured with a Clark-type O2 electrode in 2-ml stirred sample chambers at 37°C, as described by Schurig-Briccio et al. (34) . The adipocytes were harvested by trypsinization and resuspended in DMEM containing 10% calf serum, at which point the cells in the suspensions were counted in a hemocytometer (2.0 ϫ 10 6 cells/ml). The rates expressed as the slope of the O2 decline over time (nmol O 2 /min Ϯ SD) were calculated based on the O2 concentration of the medium (250 nmol/ml dissolved O2). The basal O2 consumption rate was measured for 10 min. The cells were then treated with 3 M oligomycin, 8 M FCCP, and 2 M rotenone.
Implantation. The C3H10T1/2 cells were grown in the presence or absence of BMP4 (20 ng/ml) or BMP7 (100 ng/ml). After postconfluence had been reached, they were washed, trypsinized, and resuspended in growth medium with Matrigel Matrix (BD Biosciences). Aliquots of 1.5 ϫ 10 7 cells in 0.1 ml were injected into the thoracic/ sternum region of 4-wk-old BALB/c athymic male mice with a 21-gauge needle. The mice were euthanized at 4 wk after injection, and the adipose tissue derived from the implanted cells in thoracic/ sternum region was excised and processed for histological analysis. All studies were approved by the Animal Care and Use Committee of the Fudan University Shanghai Medical College and followed the National Institutes of Health guidelines on the care and use of animals.
Histology and immunohistochemistry. Tissues were fixed overnight at 4°C in freshly prepared 4% paraformaldehyde in PBS and embedded in paraffin wax. Multiple sections were prepared and stained with hematoxylin and eosin for morphological observation. UCP1 immunohistochemistry of the tissue from the implanted cells involved a polyclonal anti-UCP1 antibody (Abcam) at a 1:50 dilution. The stained sections were examined and visualized using the AxioCam HR System (Axioskop 2 plus and AxioVision Software; Carl Zeiss Light Microscopy, Germany).
Statistical analysis. All experiments were performed at least three times, and data are expressed as means Ϯ SD. Differences were analyzed by Student's t-test between treated samples vs. control samples. P Ͻ 0.05 was considered to be statistically significant.
RESULTS
BMP4 induces brown fat-like changes in C3H10T1/2 pluripotent stem cells.
BMPs are important in the control of the stem cell commitment to various lineages. Previous reports from Tang's group (15, 40) have provided compelling evidence that BMP4 is an inducer of white adipocyte commitment at Յ25 ng/ml (40) . Another study (42) showed that 100 ng/ml (8.3 nM) BMP7 could trigger commitment of C3H10T1/2 stem cells into a brown adipocyte lineage. To compare the morphological and functional characteristic of BMP4-induced white adipocytes and BMP7-induced brown adipocytes, C3H10T1/2 stem cells were treated with 20 ng/ml purified recombinant human BMP4 or 100 ng/ml purified recombinant human BMP7 during proliferation. On reaching postconfluence, three different adipogenic induction cocktails were applied (40, 42) : insulin ϩ dexamethasone ϩ isobutylmethylxanthine (MDI, the standard induction cocktail), MDI ϩ indomethacin (MDIϩIndo, a brown adipogenic induction cocktail), and MDIϩIndoϩT 3 (a brown adipogenic induction cocktail). Cells were stained with Oil red O on day 8 after induction. Only 5-10% of cells differentiated spontaneously under induction medium (MDI) containing indomethacin and/or T 3 despite the absence of BMP4 or BMP7. Over 90% of the cells pretreated with BMP4 or BMP7 differentiated into adipocytes under the standard induction medium, which was even higher with the brown adipogenic induction cocktail containing indomethacin and/or T 3 (Fig. 1A) . Similar results were also shown by the expression of adipocyte specific markers PPAR␥2 and 422/aP2 (Fig. 1B) .
Unexpectedly, the expression of the terminal BAT-specific marker UCP1 was induced when pretreated with BMP4 or BMP7 (Fig. 1B) , and the level was much higher under the induction medium containing indomethacin and/or T 3 . This result suggests that the differentiated adipocytes derived from BMP4-pretreated cells had assumed mature brown fat-like characteristics. Consistent with the UCP1 protein level, the mRNA level of UCP1 was also induced by BMP4 in C3H10T1/2 cells (Fig. 1C) . To confirm that BMP4 could trigger the commitment of C3H10T1/2 into brown preadipocytes, the protein levels of early regulators of brown fat fate PRDM16 in the BMP4-pretreated cells were checked. The expression of PRDM16 was robustly induced within 6 days of BMP4 pretreatment (Fig. 1D) . Furthermore, a large number of brown fat-selective genes, including PGC-1␣, Cidea, Dio2, Elovl3, Cpt1b, and MACD, were markedly induced by both BMP4 and BMP7 (Fig. 1E) . Importantly, expression of PGC-1a and UCP1 was strongly induced by dibutyryl-cAMP stimulation to five-and threefold, respectively, in BMP4-pretreated cells (Fig. 1F) , indicating that the differentiated lipid-containing cells induced by BMP4 were bona fide brown adipocytes completely competent to initiate the thermogenic program.
The effects of BMPs on C3H10T1/2 stem cells are tightly controlled by the dosages: low concentrations of BMP2 and BMP7 induce adipogenic differentiation, whereas high concentrations promote differentiation toward chondrocyte and osteoblast lineages (2, 48) . Our date suggest that BMP4 is slightly more potent than BMP7 as an inducer of commitment at Յ25 ng/ml. To assess BMP4's capacity to induce brown adipogenesis, cells plated at low density were treated with BMP4 or BMP7 at 20, 50, or 100 ng/ml before introducing a brown adipogenic induction cocktail (MDIϩIndoϩT 3 ). The Oil red O staining shows that 20 ng/ml BMP4 led the accumulation of cytoplasmic triglyceride to a similar extent as that observed in the higher concentration in up to 80% of the cells (Fig. 2A) . Notably, the cells' pretreatment with BMP4 at different concentrations expressed different levels of brown fat cell-specific genes. The largest induction of UCP1 gene expression at 20 ng/ml of BMP4 reached similar levels to that of 100 ng/ml BMP7 treatment (Fig. 2B ). However, UCP1 induction level decreased at a higher concentration of BMP4 (Fig. 2B) . From the data, we conclude that BMP4 induces C3H10T1/2 cells to become brown fat-like adipocytes at Յ25 ng/ml, which is equally effective to BMP7 at 100 ng/ml.
BMP4 stimulates mitochondrial biogenesis and function. BMP4 pretreatment also caused the induction at mRNA level of PGC-1a (Fig. 1E) , which is a regulator of mitochondrial biogenesis and function. Moreover, a significant increase in the expression of genes involved in mitochondrial biogenesis, including nuclear respiratory factor 1a (Nrf1) and mitochondrial transcription factor A (Tfam), and those involved in mitochondrial oxidative phosphorylation, such as subunit VIIa 1 (Cox7a1) and subunit VIIIb (Cox8b), were found in 20 ng/ml BMP4-pretreated cells (Fig. 3A) . In particular, Cox7a1 and Cox8b, two brown fat-selective mitochondrial genes, were 50-to 200-fold higher in BMP4-pretreated cells than in control cells. This coincided with a three-to fivefold increase in mitochondrial protein content in BMP4-pretreated cells compared with control cells (Fig. 3B) . Consistent with the changes in expression of mitochondrial genes and proteins, mitochondria density was increased in both BMP4-and BMP7-pretreated cells compared with controls, as determined by transmission electron microscopy (Fig. 3C) . Mitochondria, characterized by their oval shape, and packed, parallel cristae, were abundant, and the cytoplasm was almost wholly occupied by small lipid droplets and mitochondria in BMP4-and BMP7-pretreated cells. In contrast, vehicle-treated C3H10T1/2 cells showed a lack of lipid accumulation and a reduction in mitochondrial content.
To investigate whether increased mitochondrial load elevated cellular respiration, O 2 consumption rates of BMP4-and BMP7-pretreated C3H10T1/2 cells were measured on day 8 with a Clark-type O 2 electrode. First, basal respiration was measured, followed by exposure to oligomycin, an inhibitor of ATP synthase that suppresses only oxidative phosphorylation-associated respiration and allows measurement of uncoupling respiration. Then, the uncoupler FCCP was added to measure the respiratory capacity, followed by the complex I inhibitor rotenone, which prevents electron transfer activity and leaves only nonmitochondrial activity to be measured (Fig. 4A) . BMP4-pretreated cells had a higher basal respiration than control cells, which probably originated from mitochondrial enrichment due to efficient differentiation (Fig. 4B) . In mito- A: accumulation of cytoplasmic triglyceride was detected by Oil red O staining on day 8, at which point the cells were photographed. Original magnification, ϫ40. Images represent Ն3 independent experiments. B: cell protein extract on day 8 was taken to detect expression of mature adipocyte markers (PPAR␥2, 422/aP2, and UCP1) by Western blotting. C: C3H10T1/2 cells were treated with 20 ng/ml BMP4 or 100 ng/ml BMP7 and then subjected to adipogenic induction for 8 days. RNA was isolated and level of the UCP1 mRNAs quantified with real-time PCR. D: C3H10T1/2 cells were treated with 20 ng/ml BMP4 or 100 ng/ml BMP7 until cells reached postconfluence, at which time expression of PRDM16 was measured by Western blotting. Primary stromal vascular fractions (SVF) derived from WAT and BAT were used as negative and positive control sample. E: C3H10T1/2 cells were treated with 20 ng/ml BMP4 or 100 ng/ml BMP7 for 6 days followed by adipogenic induction for 8 days. RNA was isolated, and levels of mRNAs relevant to brown fat-specific markers (PGC-1a, Cidea, Dio2, and Elovl3) and fatty acid oxidation (Cpt1b and MACD) were quantified with real-time PCR. Data are expressed as fold increase vs. control cells. F: total RNA was isolated from differentiated C3H10T1/2 stem cells pretreated with BMP4 (20 ng/ml) or BMP7 (100 ng/ml) in basal, or stimulated with 500 uM dibutyryl-cAMP for 4 h. mRNA levels of PGC1a, Nrf1, Tfam, and UCP1 were measured. Data are expressed as fold increase vs. control cells. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. ND, not detected. K, display units 1,000. Data are shown as means Ϯ SE. chondria of cells other than brown adipocytes, cellular respiration is tightly coupled to ATP synthesis. UCP1 in mitochondria of brown adipocytes, however, allows uncoupling of fuel oxidation from ATP production. To investigate whether BMP4-pretreated cells have uncoupled respiration, oligomycin-insensitive O 2 consumption was measured. In BMP4-pretreated cells, Ͼ50% of respiration was uncoupled from ATP synthesis, as judged by oligomycin-insensitive O 2 consumption (Fig. 4, A and B) , which is an attribute of brown fat (28, 29) . In contrast, oligomycin completely suppressed the respiration in unstimulated differentiated cells (Fig. 4, A and B) , indicating that nearly all cellular respiration was coupled to ATP synthesis in the absence of BMP4. This is consistent with the poor differentiation rate of C3H10T1/2 cells to mature adipocytes without BMP4 treatment (Fig. 1A) . In the presence of FCCP, an uncoupler used to maximize respiratory activity, O 2 consumption of cells without BMP4 stimulation increased fivefold (Fig. 4B) . Absolute O 2 consumption rate in BMP4-and BMP7-pretreated cells also increased, although the relative stimulation over the basal rate was leass than twofold (Fig. 4B) . The fact that FCCP had a moderate effect in BMP4-and BMP7-pretreated cells implies that basal electron transport activity of these cells is near maximal. This suggested that differentiated C3H10T1/2 cells, when pretreated with BMP4 or BMP7, resemble brown adipocytes and can execute a thermogenic program.
In vivo differentiation of BMP4-pretreated multipotent C3H10T1/2 cells into brown-like fat. Because the environmental cues that stimulate adipocyte differentiation in cell culture and in vivo are presumably different, we sought a more physiological setting to verify the role of BMP4 in this process. To this end, BMP4-and BMP7-pretreated C3H10T1/2 cells were implanted subcutaneously into athymic nude mice in the sternal region. Four weeks later, BMP4-and BMP7-pretreated cells had developed into a fat pad containing a large number of multilocular and UCP1-positive brown adipocytes and a small portion of unilocular white adipocytes, whereas no additional tissue was found in mice given vehicle-treated cells (Fig. 5) . Thus, BMP4, like BMP7, triggers the development of brown adipocytes in vivo.
BMP4 induces brown fat-like changes in the stromal-vascular fraction of white and brown fat. Stromal vascular fraction (SVF) of adipose tissue contains adipocyte progenitor cells that are characterized by their capacity for self-renewal and differentiation into mature adipocytes, thus constantly replenishing adipose tissues with newly formed adipocytes (3, 25) . To explore the brown adipogenic action of BMP4, we pretreated SVFs isolated from subcutaneous WAT and interscapular BAT of 4-wk-old wild-type C57BL6 mice with 20 ng/ml BMP4 before inducing differentiation, as shown by Oil red O staining and protein level of adipocyte-specific markers PPAR␥2 (Fig. 6, A  and B) . Whereas a few WAT-SVF-and BAT-SVF-derived primary culture cells differentiated into mature adipocytes in the absence of BMP4, almost 90% of the BMP4-pretreated cells were fully differentiated in response to the brown adipogenic induction cocktail (MDIϩIndoϩT 3 ).
Interestingly, compared with the vehicle, BMP4 pretreatment strongly induced the expression of UCP1 in BAT-SVFdifferentiated adipocytes as well as WAT-SVF-differentiated adipocytes (Fig. 6B ). This implies that BMP4 not only activates the adipogenesis program in brown preadipocytes but also induces the differentiation of brown fat-like adipocytes in white preadipocytes.
BMP4 induces brown fat-like adipocytes and increases expression of beige cell marker in both white and brown preadipocytes. Murine brown adipocytes are not all the same; the large and constitutively present interscapular BAT derives from a lineage common to skeletal muscle and is termed classical/constitutive BAT (33, 35, 41) , whereas other brown adipocytes can be induced to grow within predominantly white depots and have been termed brite/beige/inducible BAT (26, 33, 35, 51) . Since BMP4 induces the differentiation of brown fat-like adipocytes in primary white preadipocytes, we explored whether BMP4 is involved in the development of beige adipocytes. Therefore, we pretreated white preadipocyte 3T3-L1 and brown preadipocytes with BMP4 before stimulating the differentiated adipocytes with 500 M dibutyrylcAMP. While white preadipocytes pretreated with BMP4 showed a slight increase of BAT-specific gene UCP1, they responded with a significant increase in UCP1 gene expression (5-fold) following dibutyryl-cAMP stimulation (Fig. 7A) . Consistent with another report (42), BMP4-pretreated brown preadipocytes had a low basal level of UCP1 gene expression compared with BMP7-pretreated cells (Fig. 7B) . However, dibutyryl-cAMP stimulation caused BMP4-pretreated cells to respond with a very large induction of UCP1 gene expression, reaching similar levels to those in the BMP7-pretreated cells (Fig. 7B) . These data show that BMP4-pretreated cells, possessing the similar functional characteristic of beige adipocytes reported by Whittle et al. (49) , resemble white fat cells in having extremely low basal expression of UCP1 but are like classical brown fat in responding to dibutyryl-cAMP stimulation with high UCP1 expression.
Beige cells have a gene expression pattern distinct from brown fat. The genes CD137, TMEM26, and TBX1 are beige fat cell markers present in both beige fat cell precursor and mature cells, whereas EBF3, EVA1, FBXO31, and ZIC1 are the classical brown fat markers (26, 41, 46, 47, 51) . To see whether BMP4-pretreated cells have a distinct gene expression, these markers were detected in BMP4-pretreated white and brown preadipocytes. BMP4 pretreatment decreased the expression of classical/constitutive-associated marker Zic1 and increased the beige cell marker TMEM26 (Fig. 7C ). This change indicates that BMP4 induces the browning of white preadipocytes and possesses the capacity to respond to adrenergic stimulation by expressiing the genes needed for thermogenesis, making them bona fide brown adipocytes.
DISCUSSION
BAT and WAT are morphologically and functionally different tissues, and their developmental patterns are quite distinct. One of the remaining questions in adipocyte biology is how and when the specific developmental fates of brown and white adipocytes are regulated and specified. The identification of factors that induce the energy-burning brown fat in the body could lead to therapeutic strategies for combating obesity. Our experiments indicate a role of BMP4 in the brown adipogenesis of C3H10T1/2 pluripotent stem cells as well as preadipocytes.
BMP4 is known to promote the commitment of pluripotent stem cells to the white adipocyte lineage (6, 7, 35) , whereas BMP7 and BMP8B determine brown fat cell fate (37, 44) . However, a recent study shows that BMP4 can induce brown fat-like cells in the WAT by activatiing PGC-1a (30) and is involved in the terminal differentiation of brown adipocytes. Consistent with this, we can confirm a role for BMP4 as a factor that induces brown adipogenesis in C3H10T1/2 stem cells as well as preadipocytes, which results in a mature brown adipocyte phenotype characterized by elevated expression of brown fat-specific marker UCP1 (Fig. 1, B and C) and the response to adrenergic stimulation (Fig. 1F) . We found that treatment of BMP4 in C3H10T1/2 stem cells induces the Fig. 5 . Effect of BMP4 pretreatment on the capacity of C3H10T1/2 cells implanted into athymic mice to generate adipose tissue. Hematoxylin-eosin and UCP1 immunohistochemical staining of tissues derived from implantation of BMP4 (20 ng/ml) or BMP7 (100 ng/ml) -pretreated C3H10T1/2 cells into athymic mice. Development of adipose tissue from these implanted cells in endogenous subcutaneous white fat pads and interscapular brown fat pads is compared. Original magnification, ϫ400. expression of PRDM16, which is an early regulator of brown fat fate (Fig. 1D) . The data indicate that BMP4 not only induces the brown fat-like change in the mature white adipocyte (30) but stimulates stem cell commitment to the brown adipocyte lineage, probably by an autocrine/paracrine mechanism.
Differentiation of brown fat is accompanied by mitochondrial biogenesis (8) . It should be noted that BMP4 also regulates mitochondrial biogenesis and function. In C3H10T1/2 stem cells, BMP4 pretreatment significantly increases the expression of genes involved in mitochondrial biogenesis (Figs.  1E and 3A) , including PGC-1␣ as well as Nrf1, Tfam, Cox7a1, and Cox8b. This coincided with an increase in mitochondrial protein and density in BMP4-pretreated cells compared with control (Fig. 3, B and C) , the changes being associated with increased O 2 consumption and uncoupled respiration (Fig. 4) . These findings are consistent with overexpression of BMP4 in transgenic mice promoting mitochondrial biogenesis and metabolism (30) .
The fact that BMP4 completely reverses effects on inducing brown adipogenesis vs. white adipogenesis is not entirely unexpected, since the functional roles of BMP4 are cell line specific and dosage dependent and depend on, duration of exposure. In general, the dose of BMP4 used (range 5-833 ng/ml) and duration of exposure (from 48 h to 2 wk), as well as cell types, influence the data (17) . Indeed, BMP4 in our study could accumulate lipid droplets and can generally induce the expression of brown fat-specific marker UCP1 at low concentration (20 ng/ml), whereas at high concentration it had less effect on UCP1 expression (Fig. 2) . Besides the dosages and types of BMPs used in the system, the presence of extracellular and intracellular factors also controls the effects of BMPs on cells (32) . Although mesenchymal stem cells or preadipocytes are somewhat similar in their ability to differentiate into mature adipocytes, their responsiveness to adipogenic-inducing agents may vary considerably. This difference may represent the heterogeneity inherent in these cells and suggests that appropriate differentiation methods are needed according to cell type. Immortalized brown preadipocyte cells treated with orexin or BMP7 can differentiate into mature adipocytes in the absence of induction medium or in the medium containing only insulin and T 3 (36, 42) . Our data show that BMP4 could robustly induce the expression of UCP1 or other brown-fat-specific genes in the C3H10T1/2 cells in response to the normally required adipogenic induction cocktail containing indomethacin or indomethacin plus T 3 (Fig. 1) . Indomethacin, a COX2 inhibitor, stimulates adipogenic differentiation of a variety of cell lines, including TA1 (18), 3T3-L1 (50), and C3H10T1/2 (21). Likewise, our results suggest that addition of indomethacin to standard induction medium (MDI) can enhance lipid accumulation and expression of brown fatselective genes in BMP4-pretreated C3H10T1/2 cells. The molecular mechanism by which indomethacin induces brown adipognesis is unclear. Thyroid hormones are known to regulate many genes involved in lipogenesis, lipolysis, and thermogenesis in BAT (27, 43, 49) . T 3 is required for optimal UCP1 gene expression in response to noradrenergic stimulus in vivo (37) and in freshly dispersed or cultured brown adipocytes (4, 14) .
Rodent data suggest the existence of two distinct types of brown fat: classical brown fat derives from the Myf5-positive Fig. 7 . BMP4 induces brown fat-like adipocytes in white and brown preadipocytes, increases the capacity of response to cAMP stimulation and expression of beige cell marker. A and B: total RNA was isolated from differentiated white and brown preadipocytes treated with BMP4 (50 ng/ml) or BMP7 (50 ng/ml) in basal, or stimulated with dibutyryl-cAMP. Real-time PCR assayed for mRNA levels of PPAR␥ and UCP1. C: analysis of brown-and beigeselective gene expressions in undifferentiated white and brown preadipocytes treated with BMP4 (50 ng/ml) or BMP7 (50 ng/ml) for 3 days. Data are expressed as fold increase vs. control cells. *P Ͻ 0.05, **P Ͻ 0.01, ***P Ͻ 0.001. All experiments were performed in triplicate with 3 biological replicates per experiment, and data are presented as means Ϯ SE.
lineage and is located in the interscapular region of mice; beige brown fat appears in white adipose tissue or muscle from a Myf5-negative lineage (26, 41, 47) . The beige adipocytes possess many of the morphological and functional characteristics of classical brown fat but have distinct gene expression patterns (51) . Consistent with other findings (37) , our data show that BMP4-pretreated cells, like the beige brown cells, expressed very little of thermogenic gene program, including UCP1, in the unstimulated state and activated expression of UCP1 to levels that were similar to those of BMP7-pretreated cells upon cAMP stimulation (Fig. 7) . It is revealed that beige adipocytes are particularly sensitive to inductive factors, such as BMP7 (33) , BMP8B (49), fibroblast growth factor 21 (12) , and the myokine irisin (5). We found that BMP4 decreased the expression of classical brown adipocyte marker Zic1 but increased the beige adipocyte marker TMEM26 in the preadipocytes treatment with BMP4 (Fig. 7) , suggesting that BMP4 acts as a new inductive factor of the beige cells.
We therefore suggest that BMP4, in addition to inducing the formation of white adipocytes as previously reported, also induces the formation of brown adipocytes, most likely the beige adipocytes. In the presence of other extracellular and intracellular factors, BMP4 binding mainly to BMPR1A may adopt different a signaling pathway and thus yield different results. However, the underlying mechanism of BMP4 involvement in the development of beige adipocytes calls for further investigation. In addition to its general significance, this may help our understanding of adipocyte differentiation. Insight into the mechanism of action of BMP4 may reveal ways of promoting the browning phenotype in adipose depots in humans, with perspectives for altering metabolic efficiencies and thus counteracting the development of obesity-related morbidities.
